Confidential mandate

Derivatives Pricing Control Design Director

Planned Hiring / New

Derivatives Pricing Control Design Director mandate in Zurich, Switzerland

Confidential Derivatives Pricing Control Design Director in Zurich, Switzerland, reporting to the Chief Risk Officer. Consulting Quantitative Analysis appointment at Director level, a 7-month mandate horizon; four days a week.

The mandate

This consulting commission will design and prove a control framework for derivatives pricing, bounded from independent model development and production valuation. The objective is a transparent chain from trade and market inputs through approved methodology, implementation version, adjustment and price-verification outcome. The Director must turn technical differences into governed decisions rather than unexplained reserves.

Named artifacts are a pricing-method inventory, product-to-model map, market-data hierarchy, model-version control, independent price-verification design, valuation-adjustment taxonomy, tolerance framework, exception workflow, pilot report and operator handbook. Each artifact must identify evidence owner, reviewer and the point at which uncertainty requires escalation rather than automated acceptance.

Five milestones are dated: confirmed scope by 30 October 2026; inventory and risk diagnostic by 11 December; control and tolerance design by 5 February 2027; representative pilot and defect retest by 19 March; final internal reproduction and acceptance by 30 April. Acceptance rests with the Chief Risk Officer after designated valuation-control and model-risk reviewers record their challenge.

Final acceptance requires internal staff to process selected instruments, apply the approved data hierarchy, identify seeded stale-market, version and calibration exceptions, explain valuation differences and route breaches correctly. All severity-one defects must close; lower-severity limitations need named owners and dates.

Management provides approved model documentation, instrument populations, market-data sources, production outputs, existing adjustments and timely decisions. The consultant owns design, testing and transfer. Management retains pricing conclusions, model approval, entries and representations. Model redevelopment, trading strategy, independent valuation opinion, platform build and daily operation are excluded.

What you will own

  • Catalogue pricing methods, implementations, data sources and adjustment classes by instrument complexity and valuation consequence.
  • Define market-data selection, fallback, staleness and observability rules with traceable approval evidence.
  • Design independent verification tolerances that distinguish explainable uncertainty from actionable pricing difference.
  • Govern model versions, parameter changes and overrides so every production outcome links to an approved implementation.
  • Create an exception route covering quantitative decomposition, owner, materiality, escalation and closure evidence.
  • Pilot controls across representative linear, optional and path-dependent behaviour without implying product identity.
  • Train internal owners and test an independent run containing deliberately seeded failures.
  • Invoke change control for model build, system implementation, trading or recurring production requests.

Candidate qualifications

  • Demonstrate leadership of derivative pricing control across more than one valuation method or risk shape.
  • Describe a price difference you decomposed into data, calibration, implementation and methodology components.
  • Show how you set tolerances that respected uncertainty without becoming a blanket acceptance range.
  • Evidence control of model version, override and market-data hierarchy at reviewer-readable depth.
  • Provide an acceptance simulation where internal staff found and resolved seeded technical faults.
  • Explain how you kept independent valuation and model approval separate from consulting design.
  • Show milestone discipline when production or redevelopment demands pressed beyond scope.

Working terms and boundaries

  • The fixed fee covers seven months, four days weekly and five dated milestone packages.
  • The Chief Risk Officer accepts deliverables after documented internal challenge and closure of critical defects.
  • Management owns models, prices, entries and representations; the consultant owns specified design and test artifacts.
  • Late inputs enter dependency control and may adjust dates only through written change approval.
  • Model redevelopment, trading, valuation opinion, platform build and recurring operation are excluded.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 8 October 2026. Mandate reference QNT-CON-2026-ZRH-04.

More seats like this one

Every live mandate, by seat →

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.